Vimarsana
Biggest News Aggregation in the World

Page 9 - Oncological Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncological Sciences Today - Breaking & Trending Today

Rapid Test Evaluates How Immune People Are To SARS-CoV-2 Infection - Vimarsana News

Rapid Test Evaluates How Immune People Are To SARS-CoV-2 Infection

Rapid quantitative PCR test could give more accurate picture of how immune people are to SARS-CoV-2 infection by measuring T-cell immunity.

Obese men in their 60s have lower sperm counts than slimmer men in the age group, study suggests - Vimarsana News

Obese men in their 60s have lower sperm counts than slimmer men in the age group, study suggests

Scientists led by Utah University looked at 44,000 testes cells involved in the production of sperm from eight men aged between 60 and 72 years, and four men in their early 20s.

Researchers reveal how not-yet-malignant cells "turn on" and become metastatic breast cancer - Vimarsana News

Researchers reveal how not-yet-malignant cells "turn on" and become metastatic breast cancer

Mount Sinai researchers have discovered a previously unknown mechanism in which not-yet-malignant cells from early breast cancer tumors travel to other organs and, eventually, "turn on" and become metastatic breast cancer.

Scientists Discover Gene Mutation That Signals Aggressive Melanoma - Vimarsana News

Scientists Discover Gene Mutation That Signals Aggressive Melanoma

New York, NY (PRWEB) April 07, 2022 -- New York, NY (April 6, 2022)—Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a

Source: prweb.com
Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma - Vimarsana News

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them.